| 9433-4 |
Isoflurane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Isoflurane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9433-4 |
|
|
|
|
Both |
|
|
|
0 |
Isofl Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
1.0i |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 94330-8 |
Processing comment |
Find |
Specimen |
Pt |
Nom |
|
|
TRIAL |
Specimen Processing comment |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
94330-8 |
|
|
|
|
Observation |
|
|
|
0 |
Specimen Processing comment |
|
|
|
|
|
cmmt; cmnt; Com; Comm; Comments; Commt; Finding; Findings; Nominal; Point in time; Random; Remarks; Spec |
2.68 |
2.68 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 94331-6 |
Collection procedure comment |
Find |
Specimen |
Pt |
Nom |
|
|
TRIAL |
Specimen Collection procedure comment |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
94331-6 |
|
|
|
|
Observation |
|
|
|
0 |
Spec Collect proc comment |
|
|
|
|
|
cmmt; cmnt; Coll; Collect; Collect procedure comment; Collected; Com; Comm; Comments; Commt; Finding; Findings; Nominal; Point in time; Random; Remarks; Spec |
2.68 |
2.68 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 94332-4 |
Microsporidia sp 18S rRNA gene panel |
- |
XXX |
Pt |
- |
Non-probe.amp.tar |
|
ACTIVE |
Microsporidia sp 18S rRNA gene panel - Specimen by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
94332-4 |
|
Non-probe.amp.tar |
|
|
Order |
|
|
|
0 |
Microsporidia 18S rRNA Pnl NAA+non-prb |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microsporidia 18S rRNA Pnl; Microsporidiosis; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; rDNA; ribosomal RNA; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 94333-2 |
Encephalitozoon sp 18S rRNA gene |
PrThr |
XXX |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Encephalitozoon sp 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94333-2 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
Encephalitozoon 18S rRNA Spec Ql NAA+prb |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94334-0 |
Enterocytozoon bieneusi 18S rRNA gene |
PrThr |
XXX |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Enterocytozoon bieneusi 18S rRNA gene [Presence] in Specimen by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94334-0 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
E bieneusi 18S rRNA Spec Ql NAA+non-prb |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E bieneusi; E bieneusi 18S rRNA; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94335-7 |
Desmoglein 1 & Desmoglein 3 Ab.IgG panel |
- |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Desmoglein 1 and Desmoglein 3 IgG panel - Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SERO |
|
94335-7 |
|
IA |
|
|
Order |
|
|
|
0 |
Desmoglein 1+3 IgG Pnl Ser IA |
|
|
|
|
|
Desmogelin; Desmoglein 1+3 IgG Pnl; Desmoglein 3 IgG; DSG; DSG1; DSG3; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 94336-5 |
Desmoglein 1 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Desmoglein 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
94336-5 |
|
IA |
|
|
Observation |
|
|
|
0 |
Desmoglein 1 IgG Ser IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Desmogelin; Desmoglein 1 IgG; DSG; DSG1; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.68 |
2.68 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 94337-3 |
Desmoglein 3 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Desmoglein 3 IgG Ab [Units/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
94337-3 |
|
IA |
|
|
Observation |
|
|
|
0 |
Desmoglein 3 IgG Ser IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Desmogelin; Desmoglein 3 IgG; DSG; DSG3; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS |
2.68 |
2.68 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 94338-1 |
Chromosome 13+15+16+18+21+22+X+Y aneuploidy |
Find |
POC |
Pt |
Doc |
FISH |
|
ACTIVE |
Chromosome 13+15+16+18+21+22+X+Y aneuploidy in Products of Conception by FISH |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94338-1 |
|
FISH |
|
|
Both |
|
|
|
0 |
Chr 13+15+16+18+21+22+X+Y aneup POC FISH |
|
|
|
|
|
Chr 13+15+16+18+21+22+X+Y aneup; Chromosom; Chromosomes; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Point in time; Products of Conception; Random |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94339-9 |
Myelopathy autoimmune Ab panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Myelopathy autoimmune Ab panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SERO |
|
94339-9 |
|
|
|
|
Order |
|
|
|
0 |
Myelopathy Ab pnl Ser |
|
|
|
|
|
Myelopathy Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 9434-2 |
Isopropanol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Isopropanol [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
9434-2 |
|
|
|
|
Both |
|
|
|
0 |
Isopropanol Ur-mCnc |
|
|
|
Y |
|
2-propanol; c615; DRUG/TOXICOLOGY; Drugs; Isopropyl alcohol; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0i |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 94340-7 |
Amphiphysin Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Amphiphysin IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94340-7 |
|
IF |
|
|
Both |
|
|
|
0 |
Amphiphysin IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; Serum; SmQn; SR; Stiff Man Syndrome; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94341-5 |
Glial nuclear type 1 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Glial nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94341-5 |
|
IF |
|
|
Both |
|
|
|
0 |
Glial nuc type 1 IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; AGNA; AGNA-1; ANA IgG; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Glial nuc type 1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lambert-Eaton myasthenic syndrome; Neuro; Neurology; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; Random; Serology; Serum; SmQn; Sox1; Sox1 nuclear antigen; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94342-3 |
Neuronal nuclear type 1 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94342-3 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu1 IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; ANA IgG; ANNA 1; ANNA-1; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type I; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94343-1 |
Neuronal nuclear type 2 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94343-1 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu2 IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu2; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type II; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; RI; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94344-9 |
Neuronal nuclear type 3 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Neuronal nuclear type 3 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94344-9 |
|
IF |
|
|
Both |
|
|
|
0 |
Hu3 IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; ANA IgG; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type III; Nuc; Oncology; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94345-6 |
Glutamate decarboxylase 65 Ab.IgG+IgM |
SCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Glutamate decarboxylase 65 IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
SERO |
|
94345-6 |
|
IA |
|
|
Both |
|
|
|
0 |
GAD65 IgG+IgM Ser IA-sCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Insulin-Dependent Diabetes Mellitus; Level; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS |
2.68 |
2.68 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 94346-4 |
Glial fibrillary acidic protein.alpha subunit Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94346-4 |
|
IF |
|
|
Both |
|
|
|
0 |
GFAP alpha IgG Ser Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Traumatic Brain Injuries; TRF |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94347-2 |
Metabotropic glutamate receptor 1 Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94347-2 |
|
IF |
|
|
Both |
|
|
|
0 |
mGluR1 IgG Ser Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94348-0 |
Voltage-gated calcium channel N type binding Ab.IgG+IgM |
SCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Voltage-gated calcium channel N type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
SERO |
|
94348-0 |
|
IA |
|
|
Both |
|
|
|
0 |
VGCC-N Bind IgG+IgM Ser IA-sCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Inherited; Lamblia intestinalis; LEMS; Level; MEIA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCC-N Bind; Voltage-dependent calcium channels |
2.68 |
2.68 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 94349-8 |
Voltage-gated calcium channel PQ type binding Ab.IgG+IgM |
SCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Voltage-gated calcium channel P/Q type binding IgG+IgM Ab [Moles/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
SERO |
|
94349-8 |
|
IA |
|
|
Both |
|
|
|
0 |
VGCC-P/Q Bind IgG+IgM Ser IA-sCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Inherited; Lamblia intestinalis; LEMS; Level; MEIA; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCC-P/Q Bind; Voltage-dependent calcium channels |
2.68 |
2.68 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 9435-9 |
Isopropanol |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Isopropanol [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
mg/g |
|
|
|
|
|
|
DRUG/TOX |
|
9435-9 |
|
|
|
|
Both |
|
|
|
0 |
Isopropanol Tiss-mCnt |
|
|
|
Y |
|
2-propanol; c615; DRUG/TOXICOLOGY; Drugs; Isopropyl alcohol; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.7 |
1.0i |
|
|
|
|
|
|
|
mg/g |
|
|
|
0 |
| 94350-6 |
Purkinje cell cytoplasmic type 1 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-1 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94350-6 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-1 IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Yo Ab |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 94351-4 |
Purkinje cell cytoplasmic type 2 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
PCA-2 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
Titer |
|
|
|
|
|
|
SERO |
|
94351-4 |
|
IF |
|
|
Both |
|
|
|
0 |
PCA-2 IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
